Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 30, 2003

Study Completion Date

December 31, 2005

Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
DRUG

calcitriol + docetaxel

Trial Locations (11)

94589

Kaiser Permanente Medical Center (Northern California), Vallejo

94704

Alta Bates Comprehensive Cancer Center, Berkeley

97227

Kaiser Permanente Northwest, Portland

98104

Swedish Cancer Institute, Seattle

98902

Yakima Regional Cancer Care Center, Yakima

Unknown

Rocky Mountain Cancer Center, Denver

New York Oncology Hematology, P.C. - Albany Regional Cancer Center, Albany

Piedmont Hematology Oncology Associates, PLLC, Winston-Salem

Cancer Care Associates, Tulsa

Cancer Centers of the Carolinas, Greenville

Northwest Cancer Specialists, P.C., Vancouver

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Aventis Pharmaceuticals

INDUSTRY

lead

Novacea

INDUSTRY